Showing results (611-620 of 781) with videos related to

Sort By:
Pageof 79
Development (Cambridge, England)|July 24, 2014
The origin and loss of periodic patterning in the turtle shellJacqueline E Moustakas-Verho, Roland Zimm, Judith Cebra-Thomas, et al.
Cytometry|May 14, 1999
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemiaA Martínez, J F San Miguel, M B Vidriales, et al.
Neurology and Therapy|June 13, 2023
Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with MigraineJ Porta-Etessam, S Santos-Lasaosa, J Rodríguez-Vico, et al.
Cytometry|March 15, 1995
DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markersM B Vidriales, A Orfao, M C López-Berges, et al.
Brain, Behavior, and Immunity|July 29, 2015
Tumor infiltrating immune cells in gliomas and meningiomasPatrícia Domingues, María González-Tablas, Álvaro Otero, et al.
Genome Medicine|September 26, 2020
Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility lociTianlu Li, Lourdes Ortiz-Fernández, Eduardo Andrés-León, et al.
Nucleic Acids Research|December 11, 2021
Coordinated glucocorticoid receptor and MAFB action induces tolerogenesis and epigenome remodeling in dendritic cellsOctavio Morante-Palacios, Laura Ciudad, Raphael Micheroli, et al.
Microsurgery|March 29, 2014
Modified Charles procedure and lymph node flap transfer for advanced lower extremity lymphedemaStamatis Sapountzis, Pedro Ciudad, Seong Yoon Lim, et al.
Oncoimmunology|March 4, 2021
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effectNona Janikashvili, Claire Gérard, Marine Thébault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapseAna Belén Espinosa, María Dolores Tabernero, Angel Maíllo, et al.
Pageof 79